Last checked at 19 Dec 2012 14:14
19 December 2012
Revolymer plc
("Revolymer" or "the Company")
Establishment of Employee Benefit Trust, Issue of Equity and Total Voting Rights
Revolymer (AIM: REVO), the British polymer company developing patented products for a number of high value fast moving consumer goods ("FMCG") and industrial markets, announces that it has established an employee benefit trust called the Revolymer PLC Employee Benefit Trust (the "EBT"). The EBT is a discretionary trust for the potential benefit of directors and employees of the Company and its subsidiaries. Initially the EBT will be used solely to hold ordinary shares in Revolymer plc that are the subject of nil cost options granted to employees prior to the Company's admission to AIM in July 2012. The trustee of the EBT is Revolymer EBT Limited (the "Trustee"), a subsidiary of Revolymer and whose directors are John Michael Keenan and Robin James Scott Cridland.
Accordingly, the Company was notified today by the Trustee that the EBT intends to subscribe for 763,530 new ordinary shares of 1p each in the Company at an aggregate cost to the Company of £7,635.30, such shares representing 1.44% of the existing issued share capital of the Company.
Application will be made for the 763,530 new ordinary shares of 1p each, which when issued will rank pari passu with the existing ordinary shares in issue, to be admitted to trading on AIM with effect from 27 December 2012.
Following Admission, the Company's issued share capital will consist of 53,778,700 Ordinary Shares with a nominal value of 1p each, with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore the total number of Ordinary Shares in the Company with voting rights is 53,778,700.
The above figure of 53,778,700 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Service Authority's Disclosure and Transparency Rules.
Ends
For further information please contact:
Revolymer plc | +44 (0) 1244 283 500 |
Roger Pettman Rob Cridland
| |
Panmure Gordon (UK) Limited | +44 (0) 20 7886 2500 |
Callum Stewart / Adam James (Corporate Finance) Adam Pollock / Charles Leigh-Pemberton (Corporate Broking) | |
Citigate Dewe Rogerson | +44 (0)20 7638 9571 |
Simon Rigby / David Dible / Ginny Pulbrook
|
About Revolymer
Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within the global high value FMCG industry. Current applications for the Group's technologies are in the coatings & adhesives, household products and personal care markets (together "Consumer Specialties") and the confectionery chewing gum and medicated chewing gum (together "Gum") markets.
www.revolymer.com